High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening (original) (raw)
Abraham VC, Taylor L, Haskins JR (2004) High content screening applied to large-scale cell biology. Trends Biotechnol 22:15–72 ArticlePubMedCAS Google Scholar
Andrade RJ, Carmargo R, Lucena MI, Ganzalez-Grande R (2004) Causality assessment in drug-induced hepatotoxicity. Expert Opin Drug Saf 3:329–344 ArticlePubMedCAS Google Scholar
Barhoumi R, Bailey RH, Burghardt RC (1995) Kinetic analysis of glutathione in anchored cells with monochlorobimane. Cytometry 19:226–34 ArticlePubMedCAS Google Scholar
Bernardi P, Petronilli V, Di Lisa F, Forte M (2001) A mitochondrial perspective on cell death. Trends Biochem Sci 26:112–117 ArticlePubMedCAS Google Scholar
Boelsterli UA (2003a) Disease-related determinants of susceptibility to drug-induced idiosyncratic hepatotoxicity. Curr Opin Drug Discov Devel 6:81–91 CAS Google Scholar
Boelsterli UA (2003b) Idiosyncratic drug hepatotoxicity revisited: new insights from mechanistic toxicology. Toxicol Mech Methods 13:3–20 ArticleCAS Google Scholar
Brain P, Cousens R (1989) An equation to describe dose response when there is stimulation of growth at low doses. Weed Res 29:93–96 Article Google Scholar
Bugelski PJ, Atif U, Molton S, Toeg I, Lord PG, Morgan, DG. (2000) A strategy for primary high throughput cytotoxicity screening in pharmaceutical toxicology. Pharm Res 17:1265–72 ArticlePubMedCAS Google Scholar
Calabrese EJ, Baldwin LA (2002) Applications of hormesis in toxicology, risk assessment and chemotherapeutics. Trends Pharmacol Sci 23:331–337 ArticlePubMedCAS Google Scholar
Cerep (2005) In vitro Pharmacology and ADME-Tox Catalog Product No.900–59. Cerep, Redmond Google Scholar
Colombo B, Felicetti L, Baglioni C (1965) Inhibition of protein synthesis by cycloheximide in rabbit reticulocytes. Biochem Biophys Res Commun 18:389–95 ArticlePubMedCAS Google Scholar
Fung M, Thornton A, Mybeck K, Hsiao-Hui W, Hornbuckle K, Muniz E (2001) Evaluation of the characteristics of safety withdrawal of prescription drugs from worldwide pharmaceutical markets—1960–1999. Drug Inf J 35:293 – 317 Google Scholar
GenStat (2002) GenStat for Windows Release 6.1, 6th (edn.). VSN International Ltd, Oxford Google Scholar
Giuliano KA., Haskins JR, Taylor DL (2003) Advances in high content screening for drug discovery. Assay Drug Dev Technol 1:565–577 ArticlePubMedCAS Google Scholar
Graphpad Prism (2004) Graphpad Prism version 4.01 for Windows. Graphpad Software Inc, San Diego Google Scholar
Gurtu V, Kain SR, Zhang G (1997) Fluorometric and colorimetric detection of caspase activity associated with apoptosis. Anal Biochem 251:98–102 ArticlePubMedCAS Google Scholar
Haskins JR, Rowse P, Rahbari R, de La Iglesia FA (2001) Thiazolidinedione toxicity to isolated hepatocytes revealed by coherent multiprobe fluorescence microscopy and correlated with multiparameter flow cytometry of peripheral leukocytes. Arch Toxicol 75:425–438 ArticlePubMedCAS Google Scholar
Kalgutkar AS, Gardner I, Obach RS, Shaffer CL, Callegari E, Henne KR, Mutlib AE, Dalvie DK, Lee JS, Nakai Y, O’Donnell JP, Boer J, Harriman SP (2005) A comprehensive listing of bioactivation pathways of organic functional groups. Curr Drug Metab 6:1–65 Article Google Scholar
Kaplowitz N (2001) Drug-induced liver disorders. Implications for drug development and regulation. Drug Saf 24:483–490 ArticlePubMedCAS Google Scholar
Kaplowitz N (2005) Idiosyncratic drug hepatotoxicity. Nat Rev 4:489–499 CAS Google Scholar
Levesque A, Paquet A, Page M (1995) Improved fluorescent bioassay for the detection of tumor necrosis factor activity. J Immunol Methods 178:71–6 ArticlePubMedCAS Google Scholar
Lewis W, Day BJ, Copeland WC (2003) Mitochondrial toxicity of NRTI antiviral drugs: an integrated cellular perspective. Nat Rev Drug Discov 2:812–822 ArticlePubMedCAS Google Scholar
Lorico A, Masturzo P, Villa S, Salmona M, Semeraro N, de Gaetano G (1986) Gentisic acid: an aspirin metabolite with multiple effects on human blood polymorphonuclear leukocytes. Biochem Pharmacol 35:2443–5 ArticlePubMedCAS Google Scholar
Meselson M, Stahl FW (1958) The replication of DNA. Cold Spring Harb Symp Quant Biol 23:9–12 PubMedCAS Google Scholar
Nociari MM, Shalev A, Benias P, Russo C (1998) A novel one-step, highly sensitive fluorometric assay to evaluate cell-mediated cytotoxicity. J Immunol Methods 213:157–67 ArticlePubMedCAS Google Scholar
O’Brien PJ, Kalow BI, Brown BD, Lumsden JH, Jacobs RM (1989) Porcine malignant hyperthermia susceptibility: halothane-induced increase in cytoplasmic free calcium of peripheral blood lymphocytes. Am J Vet Res 50:131–135 PubMed Google Scholar
O’Brien PJ, Kalow BI, Ali N, Lassaline LA, Lumsden JH (1990) Compensatory increase in calcium extrusion activity of untreated lymphocytes from swine susceptible to malignant hyperthermia. Am J Vet Res 51:1038–1043 PubMed Google Scholar
O’Brien PJ, Slaughter MR, Biagini C, Diaz D, Gao, B, Irwin W, Krejsa C, Hougham C, Abraham V, Haskins JR (2003) Predicting drug-induced human hepatotoxicity with in vitro cytotoxicity assays. In: Proceedings Tox ’03, London, UK
Olson H, Betton G, Stritar J, Robinson D (1998) The predictivity of the toxicity of pharmaceuticals in humans from animal data—an interim assessment. Toxicol Lett 102–103:535–538 ArticlePubMed Google Scholar
Olson H, Betton G, Robinson D, Thomas K, Monro A, Kolaja G, Lilly P, Sanders J, Sipes G, Bracken W, Dorato M, Van Deun K, Smith P, Berger B, Heller A (2000) Concordance of the toxicity of pharmaceuticals in humans and in animals. Regul Toxicol Pharmacol 32:56–67 ArticlePubMedCAS Google Scholar
Olson H, Kadyszewski E, Beierschmitt W (2001) Hormesis—a pharmaceutical industry perspective. Crit Rev Toxicol 31:659–61 ArticlePubMedCAS Google Scholar
Phillips GW, Irwin WA, Howard-Cofield EJ, Randle LE, Abraham V, Haskins J, O’Brien PJ (2005) Incorporation of an oxidative stress biomarker into high content screening (HCS) for human toxicity potential. Proc Soc Biomol Screen
Plymale DR, Haskins JR, De La Iglesia FA (1999) Monitoring of simultaneous subcellular events in vitro by means of coherent multiprobe fluorescence. Nat Med 5:351–355 ArticlePubMedCAS Google Scholar
Russo MW, Galanko JA, Shrestha R, Fried MW, Watkins P (2004) Liver transplantation for acute liver failure from drug-induced liver injury in the United States. Liver Transpl 10:1018–1023 ArticlePubMed Google Scholar
Schoonen WGEJ, Westerink WMA, de Roos JADM, Debiton E. (2005a) Cytotoxic effects of 100 reference compounds on Hep G2 and HeLa cells and of 60 compounds on ECC-1 and CHO cells. I. Mechanistic assays on ROS, glutathione depletion and calcein uptake. Toxicol In Vitro 19:505–516 ArticleCAS Google Scholar
Schoonen WGEJ, Westerink WMA, de Roos JADM, Debiton E. (2005b) Cytotoxic effects of 110 reference compounds on Hep G2 and for 60 compounds on HeLa, ECC-1 and CHO cells. I. Mechanistic assays on NAD(P)H, ATP, and DNA contents. Toxicol In Vitro 19:491–503 ArticleCAS Google Scholar
Slaughter MR, Thakkar H, O’Brien PJ (2002) Effect of diquat on the antioxidant system and cell growth in human neuroblastoma cells. Toxicol Appl Pharmacol 178:63–70 ArticlePubMedCAS Google Scholar
Xu JJ, Diaz D, O’Brien PJ (2004). Applications of cytotoxicity assays and pre-lethal mechanistic assays for assessment of human hepatotoxicity potential. Chem Biol Interact 150:115–128 ArticlePubMedCAS Google Scholar